Concepedia

Sarah M. McWhirter

SM

30

Publications

9.1K

Citations

26

H-Index

1999

Active since

Affiliations

University of California, Berkeley(Current)

Aduro BioTech (United States)

Harvard University

University of Massachusetts Chan Medical School

Sidney Kimmel Comprehensive Cancer Center

Sarah M. McWhirter is an author at University of California, Berkeley specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1999–2025

30

Publications

30

IKKε and TBK1 are essential components of the IRF3 signaling pathway

Katherine A. Fitzgerald, Sarah M. McWhirter, L. Kerrie et al. · Nature Immunology · 2003 · 2.7K citations

, , +9

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports · 2015 · 1.4K citations · Full text

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 681 citations

IFN-regulatory factor 3-dependent gene expression is defective in <i>Tbk1</i> -deficient mouse embryonic fibroblasts

Sarah M. McWhirter, Katherine A. Fitzgerald, Jacqueline Rosains et al. · Proceedings of the National Academy of Sciences · 2003 · 534 citations · Full text

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 417 citations · Full text

Rows per page

1–5 of 30